Amylin Pharmaceuticals (AMLN) 10% Owner, Black Bear Offshore Master Fund, Buys 894K Shares
More News related to AMLN
- Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
- Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDA's BYETTA(R) (Exenatide) Injection Update
- FDA: Byetta Label Revised to Include Safety Information on Possible Kidney Problems
- Unusual 11 Mid-Day Movers 11/02: HGSI, EAC, IUSA, VRTX Higher; CIT, YRCW, GTXI, CPF Lower
- Hapoalim Securities Upgrades Amylin (AMLN) to Hold; Two Important Milestones Achieved
Amylin Pharmaceuticals Inc. (Nasdaq: AMLN) 10% beneficial owner, Black Bear Offshore Master Fund, purchased 894,000 shares of Amylin on 4/21 at prices ranging from $28.52-$29.55, bringing its stake to 15,674,698 shares.
Amylin Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of medicines for diabetes, obesity, and other diseases in the United States. [BCS]
Related Categories
Insider TradesStocks Mentioned
+0.32Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
